India · Delayed Price · Currency is INR Fredun Pharmaceuticals Statistics
Total Valuation
BOM:539730 has a market cap or net worth of INR 5.88 billion. The enterprise value is 7.49 billion.
| Market Cap | 5.88B |
| Enterprise Value | 7.49B |
Important Dates
The next estimated earnings date is Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | Sep 23, 2025 |
Share Statistics
BOM:539730 has 4.70 million shares outstanding. The number of shares has decreased by -5.61% in one year.
| Current Share Class | 4.70M |
| Shares Outstanding | 4.70M |
| Shares Change (YoY) | -5.61% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 42.59% |
| Owned by Institutions (%) | 1.60% |
| Float | 2.70M |
Valuation Ratios
The trailing PE ratio is 24.66.
| PE Ratio | 24.66 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 4.16 |
| P/TBV Ratio | 4.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 33.49 |
| EV / Sales | 1.51 |
| EV / EBITDA | 12.21 |
| EV / EBIT | 13.38 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 2.72 |
| Debt / FCF | n/a |
| Interest Coverage | 2.24 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.07% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 19.43M |
| Profits Per Employee | 874,031 |
| Employee Count | 256 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:539730 has paid 86.40 million in taxes.
| Income Tax | 86.40M |
| Effective Tax Rate | 27.86% |
Stock Price Statistics
The stock price has increased by +61.74% in the last 52 weeks. The beta is 0.86, so BOM:539730's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | +61.74% |
| 50-Day Moving Average | 1,020.46 |
| 200-Day Moving Average | 792.23 |
| Relative Strength Index (RSI) | 66.94 |
| Average Volume (20 Days) | 22,151 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:539730 had revenue of INR 4.97 billion and earned 223.75 million in profits. Earnings per share was 50.75.
| Revenue | 4.97B |
| Gross Profit | 1.22B |
| Operating Income | 560.11M |
| Pretax Income | 310.15M |
| Net Income | 223.75M |
| EBITDA | 613.75M |
| EBIT | 560.11M |
| Earnings Per Share (EPS) | 50.75 |
Balance Sheet
The company has 59.73 million in cash and 1.67 billion in debt, giving a net cash position of -1.61 billion or -342.98 per share.
| Cash & Cash Equivalents | 59.73M |
| Total Debt | 1.67B |
| Net Cash | -1.61B |
| Net Cash Per Share | -342.98 |
| Equity (Book Value) | 1.41B |
| Book Value Per Share | 321.09 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 24.63%, with operating and profit margins of 11.26% and 4.50%.
| Gross Margin | 24.63% |
| Operating Margin | 11.26% |
| Pretax Margin | 6.24% |
| Profit Margin | 4.50% |
| EBITDA Margin | 12.34% |
| EBIT Margin | 11.26% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 0.05%.
| Dividend Per Share | 0.70 |
| Dividend Yield | 0.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.61% |
| Shareholder Yield | 5.66% |
| Earnings Yield | 3.80% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |